Nandlal Rathi

Prevalence of First Diagnosed Atrial Fibrillation in Patients Admitted with Acute Coronary Syndrome and with Impaired Renal Function with and without Diabetes Mellitus

Nandlal Rathi, Muhammad Zaman Balouch, Shazia Kazi, Salman Ahmed, Abdul Mueed & Abdul Ghani Shaikh · Journal of Pharmaceutical Research International · 2021

Objective: To determine the prevalence of first diagnosed atrial fibrillation in patients admitted with acute coronary syndrome and with impaired renal function with and without diabetes mellitus. Methodology: A total of 434 patients were selected from two different hospitals, 36...

Open access Research Article 10.9734/jpri/2021/v33i28B31544

Quality of Life after Ablation vs Medication Therapy in Patients With Supraventricular Tachycardia

Abdul Mueed, Nandlal Rathi, . Shahzad, Jibran Ashraf, Salman Ahmed & Lajpat Rai · Journal of Pharmaceutical Research International · 2021

Objective: Supraventricular tachycardia (SVT) is the most common presentation of patients at cardiac emergency department. This study aims to determine the quality of life in patients with supraventricular tachycardia after they treated with medicines vs. ablation therapy. Method...

Open access Research Article 10.9734/jpri/2021/v33i31B31694

In Hospital Frequency of Heart Failure in STEMI after Thrombolysis in Patient with Diabetes

Abdul Mueed, Nandlal Rathi, Shazia Kazi, Raj Kumar Sachdewani, . Shahzad & Jibran Ashraf · Journal of Pharmaceutical Research International · 2021

Objective: To determine the frequency of heart failure after thrombolysis in STEMI patients with diabetes mellitus. Methodology: Through a prospective study we have enrolled all the diabetic patients who presented with acute ST-Segment Elevation Myocardial Infarction (STEMI) havi...

Open access Research Article 10.9734/jpri/2021/v33i1131245